Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis

Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the subtypes alopecia totalis and alopecia universalis...

Full description

Bibliographic Details
Main Authors: Nicolae Done, Lauren Bartolome, Elyse Swallow, Wei Gao, Christopher Carley, Travis Wang, Arash Mostaghimi
Format: Article
Language:English
Published: Medical Journals Sweden 2023-08-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access:https://medicaljournalssweden.se/actadv/article/view/12445
_version_ 1797737214070751232
author Nicolae Done
Lauren Bartolome
Elyse Swallow
Wei Gao
Christopher Carley
Travis Wang
Arash Mostaghimi
author_facet Nicolae Done
Lauren Bartolome
Elyse Swallow
Wei Gao
Christopher Carley
Travis Wang
Arash Mostaghimi
author_sort Nicolae Done
collection DOAJ
description Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the subtypes alopecia totalis and alopecia universalis, in the first year after diagnosis of an episode of alopecia areata. Approximately 5% of all patients (adults (age ≥ 18 years), n = 7,703; adolescents (age 12–17 years), n = 595) had alopecia totalis or alopecia universalis. Corticosteroids were the most common first-line (1L) and second-line (2L) treatments. The mean time from diagnosis of alopecia areata to initiation of 1L treatment was 2.2 days for adults and 2.6 days for adolescents; mean 1L duration was 76.9 and 64.3 days, respectively. For adults (57.5%) and adolescents (59.7%) with 2L therapy, the mean time from 1L discontinuation to 2L initiation was 57.2 and 53.6 days, respectively; the mean duration of 2L treatment was 55.5 and 50.1 days, respectively. More patients with vs without alopecia totalis or alopecia universalis initiated 2L therapy (adults: 71.9% vs 56.8%; adolescents: 71.4% vs 58.9%). The proportion of days covered during the first year post-diagnosis was 36.7% (adults) and 34.1% (adolescents). These results highlight the substantial disease burden of alopecia areata and a need for more effective treatments.
first_indexed 2024-03-12T13:25:14Z
format Article
id doaj.art-5366461a22b8455b864b6c81d608c406
institution Directory Open Access Journal
issn 0001-5555
1651-2057
language English
last_indexed 2024-03-12T13:25:14Z
publishDate 2023-08-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj.art-5366461a22b8455b864b6c81d608c4062023-08-25T08:03:12ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572023-08-0110310.2340/actadv.v103.12445Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims AnalysisNicolae Done0Lauren Bartolome1Elyse Swallow2Wei Gao3Christopher Carley4Travis Wang5Arash Mostaghimi6Analysis Group, Boston, MA, USPfizer, Collegeville, PA, USAAnalysis Group, Boston, MA, USAnalysis Group, Boston, MA, USAnalysis Group, Boston, MA, USAnalysis Group, Boston, MA, USBrigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAAlopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the subtypes alopecia totalis and alopecia universalis, in the first year after diagnosis of an episode of alopecia areata. Approximately 5% of all patients (adults (age ≥ 18 years), n = 7,703; adolescents (age 12–17 years), n = 595) had alopecia totalis or alopecia universalis. Corticosteroids were the most common first-line (1L) and second-line (2L) treatments. The mean time from diagnosis of alopecia areata to initiation of 1L treatment was 2.2 days for adults and 2.6 days for adolescents; mean 1L duration was 76.9 and 64.3 days, respectively. For adults (57.5%) and adolescents (59.7%) with 2L therapy, the mean time from 1L discontinuation to 2L initiation was 57.2 and 53.6 days, respectively; the mean duration of 2L treatment was 55.5 and 50.1 days, respectively. More patients with vs without alopecia totalis or alopecia universalis initiated 2L therapy (adults: 71.9% vs 56.8%; adolescents: 71.4% vs 58.9%). The proportion of days covered during the first year post-diagnosis was 36.7% (adults) and 34.1% (adolescents). These results highlight the substantial disease burden of alopecia areata and a need for more effective treatments. https://medicaljournalssweden.se/actadv/article/view/12445alopecia areataalopecia totalisalopecia universalistreatmentadultadolescent
spellingShingle Nicolae Done
Lauren Bartolome
Elyse Swallow
Wei Gao
Christopher Carley
Travis Wang
Arash Mostaghimi
Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
Acta Dermato-Venereologica
alopecia areata
alopecia totalis
alopecia universalis
treatment
adult
adolescent
title Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
title_full Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
title_fullStr Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
title_full_unstemmed Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
title_short Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
title_sort real world treatment patterns among patients with alopecia areata in the usa a retrospective claims analysis
topic alopecia areata
alopecia totalis
alopecia universalis
treatment
adult
adolescent
url https://medicaljournalssweden.se/actadv/article/view/12445
work_keys_str_mv AT nicolaedone realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis
AT laurenbartolome realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis
AT elyseswallow realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis
AT weigao realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis
AT christophercarley realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis
AT traviswang realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis
AT arashmostaghimi realworldtreatmentpatternsamongpatientswithalopeciaareataintheusaaretrospectiveclaimsanalysis